Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Cancer. 2009 Mar 1;115(5):1028–1035. doi: 10.1002/cncr.24084

TABLE 2.

CHARACTERISTICS OF PATIENTS WITH NORMAL PRETREATMENT CA-125

Distribution of 99 Patients with Normal Pretreatment CA-125 Percentage of Patients in Each Subgroup with Normal Pretreatment CA-125
Stage
 III- optimal microscopic 40.4% 16.0%
 III- optimal gross 39.3% 8.8%
 III- suboptimal 15.2% 3.6%
 IV 5.1% 2.7%
Histologic Subtype
 Serous 64.6% 6.8%
 Endometrioid 6.1% 5.2%
 Mucinous 8.1% 30.8%
 Clear Cell 3.0% 8.1%
 Other 18.2% 9.8%